Applied BioCode (TPE:6598) Ending Cash Position : NT$606.0 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Applied BioCode Ending Cash Position?

Applied BioCode's Ending Cash Position for the quarter that ended in Dec. 2024 was NT$606.0 Mil.

Applied BioCode's quarterly Ending Cash Position increased from Jun. 2024 (NT$455.4 Mil) to Sep. 2024 (NT$811.8 Mil) but then declined from Sep. 2024 (NT$811.8 Mil) to Dec. 2024 (NT$606.0 Mil).

Applied BioCode's annual Ending Cash Position declined from Dec. 2022 (NT$831.3 Mil) to Dec. 2023 (NT$413.2 Mil) but then increased from Dec. 2023 (NT$413.2 Mil) to Dec. 2024 (NT$606.0 Mil).

Applied BioCode Ending Cash Position Historical Data

The historical data trend for Applied BioCode's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied BioCode Ending Cash Position Chart

Applied BioCode Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

847.91

646.07

831.32

413.19

605.96

Applied BioCode Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															413.19	489.24	455.44	811.84	605.96

Applied BioCode Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Applied BioCode's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	413.194	+	192.764
	=	606.0

Applied BioCode's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	811.843	+	-205.885
	=	606.0

Applied BioCode Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Applied BioCode's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied BioCode Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Applied BioCode Corp (TPE:6598) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

12130 Mora Dr., Unit 2,, Santa Fe Springs, CA, USA, 90670

Website

https://www.apbiocode.com

Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.

Applied BioCode Headlines

No Headlines